Criteria and Non-Criteria Antiphospholipid Antibodies and Cancer in Patients with Involuntary Weight Loss.
antiphospholipid antibodies
cancer
involuntary weight loss
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
29 Oct 2023
29 Oct 2023
Historique:
received:
25
09
2023
revised:
25
10
2023
accepted:
27
10
2023
medline:
25
11
2023
pubmed:
25
11
2023
entrez:
25
11
2023
Statut:
epublish
Résumé
Cancer patients have higher prevalences of antiphospholipid antibodies (aPLs), occasionally associated with thrombotic events. A cross-sectional study regarding the presence of criteria (IgG/IgM anti-cardiolipin-aCL, anti-β2 glycoprotein I-aβ2GPI) and non-criteria (IgG/IgM anti-phosphatidylserine-aPS, anti-phosphatidylethanolamine-aPE, anti-prothrombin-aPT) aPLs in 146 patients with involuntary weight loss was performed. None of the patients had thrombotic events during the study. Out of the 36 cancer patients, 33 had non-hematologic malignancies. In the cancer subgroup, 60% of the patients had at least one positive aPL, with significantly more patients being positive for aβ2GPI IgG compared with the non-cancer subgroup-
Identifiants
pubmed: 38003864
pii: jpm13111549
doi: 10.3390/jpm13111549
pmc: PMC10671946
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : CNCSIS-UEFISCSU
ID : IDEI 10/2008
Références
PLoS One. 2017 Apr 7;12(4):e0175125
pubmed: 28388637
J Med Vasc. 2020 Nov;45(6S):6S3-6S7
pubmed: 33276941
PLoS One. 2023 Jan 20;18(1):e0279450
pubmed: 36662720
Blood Adv. 2020 Apr 28;4(8):1746-1755
pubmed: 32337583
Front Immunol. 2022 Oct 26;13:972012
pubmed: 36389827
Semin Cancer Biol. 2020 Aug;64:108-113
pubmed: 31351197
J Investig Med. 2012 Jun;60(5):827-9
pubmed: 22481167
J Thromb Thrombolysis. 2023 Aug;56(2):301-314
pubmed: 37264223
Ann Rheum Dis. 2019 Oct;78(10):1296-1304
pubmed: 31092409
Pol Arch Intern Med. 2020 Dec 22;130(12):1037-1042
pubmed: 32975920
Cancers (Basel). 2018 Oct 11;10(10):
pubmed: 30314362
Pol Arch Intern Med. 2020 Dec 22;130(12):1026-1028
pubmed: 33355433
Autoimmun Rev. 2011 Feb;10(4):222-7
pubmed: 20955822
J Crit Care. 2014 Aug;29(4):533-8
pubmed: 24629573
Lupus. 2003;12(2):112-6
pubmed: 12630755
Clin Rheumatol. 2007 Jan;26(1):95-7
pubmed: 16721493
Cancers (Basel). 2023 Mar 31;15(7):
pubmed: 37046748
PLoS One. 2014 Apr 24;9(4):e95286
pubmed: 24762986
Am Fam Physician. 2021 Jul 1;104(1):34-40
pubmed: 34264616
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620928392
pubmed: 32633133
Semin Arthritis Rheum. 2006 Apr;35(5):322-32
pubmed: 16616155
Int J Mol Sci. 2022 Apr 08;23(8):
pubmed: 35456969
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221088576
pubmed: 35317658
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620954282
pubmed: 32877229
Clin Rev Allergy Immunol. 2007 Apr;32(2):184-7
pubmed: 17916991
Br J Cancer. 1995 Aug;72(2):447-51
pubmed: 7640230
Autoimmun Rev. 2010 Feb;9(4):200-2
pubmed: 19386286
Biomedicines. 2023 Aug 03;11(8):
pubmed: 37626689
BMC Gastroenterol. 2012 Jul 09;12:86
pubmed: 22776590
Support Care Cancer. 2020 Jan;28(1):329-339
pubmed: 31049669
Antibodies (Basel). 2016 Aug 02;5(3):
pubmed: 31557999
Int J Gen Med. 2023 Jan 22;16:259-272
pubmed: 36711430
Biomedicine (Taipei). 2018 Dec;8(4):25
pubmed: 30474606
Intern Emerg Med. 2009 Dec;4(6):491-5
pubmed: 19784751
Kardiol Pol. 2023;81(10):1047-1063
pubmed: 37660389